Faeth Therapeutics, Inc. (FTH) vs OmniAb, Inc. (OABI)

A side-by-side comparison of Faeth Therapeutics, Inc. and OmniAb, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FTH vs OABI

growth of $100 · dividends reinvested · last 5y
FTH -87.5% (-34.0%/yr)OABI -49.6% (-12.8%/yr)OABI compounded faster over this window
020406080100Start $10020222023202420252026$12$50
FTH OABI

FTH vs OABI: by the numbers

  • •FTH is the larger company ($745M vs $643M market cap).
  • •Both run net losses; FTH's is the smaller (0.00% vs -115.18% net margin).

Metrics side by side

Valuation

MetricFTHOABI
P/S ratioN/A16.73
P/B ratio4.312.47

Profitability

MetricFTHOABI
Gross margin0.00%-18.17%
Operating margin0.00%-383.15%
Net margin0.00%-115.18%
ROE-113.05%-17.01%
ROIC-110.62%-17.48%

Growth (annualized)

MetricFTHOABI
Revenue CAGR (5Y)N/A-4.31%
Total return CAGR (5Y)-31.75%-13.17%

Frequently asked

How have FTH and OABI total returns compared?
Over the past 5 years, FTH delivered -31.75% and OABI delivered -13.17% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.